MedPath

Post-Market Clinical Data Analysis With Skanrays Defibrillators (Clinical study to record the safety and performance data of Skanrays Defibrillators in real world scenario)

Phase 4
Conditions
Health Condition 1: R001- Bradycardia, unspecifiedHealth Condition 2: I468- Cardiac arrest due to other underlying conditionHealth Condition 3: I462- Cardiac arrest due to underlying cardiac conditionHealth Condition 4: I469- Cardiac arrest, cause unspecifiedHealth Condition 5: I482- Chronic atrial fibrillationHealth Condition 6: I480- Paroxysmal atrial fibrillationHealth Condition 7: I481- Persistent atrial fibrillationHealth Condition 8: I489- Unspecified atrial fibrillation and atrial flutter
Registration Number
CTRI/2023/05/053279
Lead Sponsor
Skanray Technologies Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Data from the subject that meets the below-mentioned criteria shall be collected.

? Patients with indications for defibrillation/cardioversion/pacing.

? Male and female subjects who weigh above 10 kg.

Exclusion Criteria

? Unsafe conditions or surroundings for the use of Direct Current

? Contraindications for defibrillation

A A responsive patient with spontaneous breathing and a palpable pulse.

B Asystole or pulseless electrical activity PEA

? Contraindications for cardioversion - arrhythmias due to enhanced automaticity, such as

digitalis toxicity of digitalis-associated tachycardia, sinus tachycardia, multifocal atrial

tachycardia and junctional tachycardia. Catecholamine-induced arrhythmia having a

homogeneous depolarization state Eg CPVT, shall be excluded.

? Contraindications for pacing - asymptomatic subjects with a reasonably stable rhythm.

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath